132 related articles for article (PubMed ID: 32206255)
1. Synthesis of montbretin A analogues yields potent competitive inhibitors of human pancreatic α-amylase.
Tysoe CR; Caner S; Calvert MB; Win-Mason A; Brayer GD; Withers SG
Chem Sci; 2019 Dec; 10(48):11073-11077. PubMed ID: 32206255
[TBL] [Abstract][Full Text] [Related]
2. The amylase inhibitor montbretin A reveals a new glycosidase inhibition motif.
Williams LK; Zhang X; Caner S; Tysoe C; Nguyen NT; Wicki J; Williams DE; Coleman J; McNeill JH; Yuen V; Andersen RJ; Withers SG; Brayer GD
Nat Chem Biol; 2015 Sep; 11(9):691-6. PubMed ID: 26214255
[TBL] [Abstract][Full Text] [Related]
3. Branched montbretin A mimics allow derivatisation and potent amylase inhibition.
Calvert M; Sweeney RP; Chen HM; Bajwa H; Nasseri SA; Habibi D; Withers SG
Org Biomol Chem; 2023 Oct; 21(39):7977-7983. PubMed ID: 37751159
[TBL] [Abstract][Full Text] [Related]
4. Acarbose rearrangement mechanism implied by the kinetic and structural analysis of human pancreatic alpha-amylase in complex with analogues and their elongated counterparts.
Li C; Begum A; Numao S; Park KH; Withers SG; Brayer GD
Biochemistry; 2005 Mar; 44(9):3347-57. PubMed ID: 15736945
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based inhibition of yeast alpha-glucosidase and human pancreatic alpha-amylase by a new class of inhibitors. 2-Deoxy-2,2-difluoro-alpha-glycosides.
Braun C; Brayer GD; Withers SG
J Biol Chem; 1995 Nov; 270(45):26778-81. PubMed ID: 7592915
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of beta-glycosidases by acarbose analogues containing cellobiose and lactose structures.
Lee SB; Park KH; Robyt JF
Carbohydr Res; 2001 Mar; 331(1):13-8. PubMed ID: 11284501
[TBL] [Abstract][Full Text] [Related]
7. Glucose lowering effect of montbretin A in Zucker Diabetic Fatty rats.
Yuen VG; Coleman J; Withers SG; Andersen RJ; Brayer GD; Mustafa S; McNeill JH
Mol Cell Biochem; 2016 Jan; 411(1-2):373-81. PubMed ID: 26547551
[TBL] [Abstract][Full Text] [Related]
8. A cyclic phosphonamidate analogue of glucose as a selective inhibitor of inverting glycosidases.
Darrow JW; Drueckhammer DG
Bioorg Med Chem; 1996 Aug; 4(8):1341-8. PubMed ID: 8879556
[TBL] [Abstract][Full Text] [Related]
9. RBI, a one-domain alpha-amylase/trypsin inhibitor with completely independent binding sites.
Maskos K; Huber-Wunderlich M; Glockshuber R
FEBS Lett; 1996 Nov; 397(1):11-6. PubMed ID: 8941704
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular docking and QSAR study of thiazole clubbed pyrazole hybrid as α-amylase inhibitor.
Duhan M; Singh R; Devi M; Sindhu J; Bhatia R; Kumar A; Kumar P
J Biomol Struct Dyn; 2021 Jan; 39(1):91-107. PubMed ID: 31838966
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study.
Taha M; Alrashedy AS; Almandil NB; Iqbal N; Anouar EH; Nawaz M; Uddin N; Chigurupati S; Wadood A; Rahim F; Das S; Venugopal V; Nawaz F; Khan KM
Int J Biol Macromol; 2021 Nov; 190():301-318. PubMed ID: 34481854
[TBL] [Abstract][Full Text] [Related]
12. Cyclic amidine sugars as transition-state analogue inhibitors of glycosidases: potent competitive inhibitors of mannosidases.
Heck MP; Vincent SP; Murray BW; Bellamy F; Wong CH; Mioskowski C
J Am Chem Soc; 2004 Feb; 126(7):1971-9. PubMed ID: 14971930
[TBL] [Abstract][Full Text] [Related]
13. Arylureidoaurones: Synthesis, in vitro α-glucosidase, and α-amylase inhibition activity.
Kazempour-Dizaji M; Mojtabavi S; Sadri A; Ghanbarpour A; Faramarzi MA; Navidpour L
Bioorg Chem; 2023 Oct; 139():106709. PubMed ID: 37442042
[TBL] [Abstract][Full Text] [Related]
14. Potent Human α-Amylase Inhibition by the β-Defensin-like Protein Helianthamide.
Tysoe C; Williams LK; Keyzers R; Nguyen NT; Tarling C; Wicki J; Goddard-Borger ED; Aguda AH; Perry S; Foster LJ; Andersen RJ; Brayer GD; Withers SG
ACS Cent Sci; 2016 Mar; 2(3):154-161. PubMed ID: 27066537
[TBL] [Abstract][Full Text] [Related]
15. The search for novel human pancreatic alpha-amylase inhibitors: high-throughput screening of terrestrial and marine natural product extracts.
Tarling CA; Woods K; Zhang R; Brastianos HC; Brayer GD; Andersen RJ; Withers SG
Chembiochem; 2008 Feb; 9(3):433-8. PubMed ID: 18214874
[TBL] [Abstract][Full Text] [Related]
16. Structural biology of starch-degrading enzymes and their regulation.
Møller MS; Svensson B
Curr Opin Struct Biol; 2016 Oct; 40():33-42. PubMed ID: 27450115
[TBL] [Abstract][Full Text] [Related]
17. Alternative catalytic anions differentially modulate human alpha-amylase activity and specificity.
Maurus R; Begum A; Williams LK; Fredriksen JR; Zhang R; Withers SG; Brayer GD
Biochemistry; 2008 Mar; 47(11):3332-44. PubMed ID: 18284212
[TBL] [Abstract][Full Text] [Related]
18. Inhibition and binding modes of low-molecular-weight inhibitors of porcine pancreatic alpha-amylase.
Yamashita H; Nakatani H; Tonomura B
J Biochem; 1992 Feb; 111(2):182-5. PubMed ID: 1569042
[TBL] [Abstract][Full Text] [Related]
19. Novel oxadiazole derivatives as potent inhibitors of α-amylase and α-glucosidase enzymes: Synthesis,
Bukhari A; Nadeem H; Imran M; Muhammad SA
Iran J Basic Med Sci; 2021 Dec; 24(12):1632-1642. PubMed ID: 35432813
[TBL] [Abstract][Full Text] [Related]
20. Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics.
Shahzad D; Saeed A; Larik FA; Channar PA; Abbas Q; Alajmi MF; Arshad MI; Erben MF; Hassan M; Raza H; Seo SY; El-Seedi HR
Molecules; 2019 Apr; 24(8):. PubMed ID: 30999646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
